Cargando…
OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
OBJECTIVE: To report the pregnancy outcomes on patients with chronic migraine exposed to onabotulinumtoxinA from Hull Headache Clinic. BACKGROUND: Migraines are common in women of reproductive age and those with chronic migraine have a major impact on their activities of daily living and health-rela...
Autores principales: | Wong, Ho-Tin, Khalil, Modar, Ahmed, Fayyaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599093/ https://www.ncbi.nlm.nih.gov/pubmed/33121432 http://dx.doi.org/10.1186/s10194-020-01196-1 |
Ejemplares similares
-
Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse
por: Ahmed, Fayyaz, et al.
Publicado: (2015) -
Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
por: Khalil, Modar, et al.
Publicado: (2014) -
OnabotulinumtoxinA for chronic migraine: a critical appraisal
por: Gooriah, Rubesh, et al.
Publicado: (2015) -
Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine
por: Rothrock, John F, et al.
Publicado: (2014) -
Safety of OnabotulinumtoxinA in the [management of] chronic migraine in pregnancy
por: Smirnoff, Liza
Publicado: (2022)